Evidence map›Paper›PMID 27071112›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Cofactor bypass variants reveal a conformational control mechanism governing cell wall polymerase activity.

Monica Markovski, Jessica L Bohrhunter, Tania J Lupoli, Tsuyoshi Uehara, Suzanne Walker, Daniel E Kahne, Thomas G Bernhardt

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Influence of Outer Membrane Protein on Ampicillin Resistance ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. The LpoA activator is required to stimulate the peptidoglycan polymerase activity of its cognate cell wall synthase PBP1a.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. Regulation of peptidoglycan synthesis and remodelling.Nature reviews. Microbiology · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Monica MarkovskiDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115;
Jessica L BohrhunterDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115;
Tania J LupoliDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138;
Tsuyoshi UeharaDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115;
Suzanne WalkerDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138;
Daniel E KahneDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.
Thomas G BernhardtDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115; thomas_bernhardt@hms.harvard.edu.
Harvard University · US

Funding

Targeting bacterial cell wall biogenesis for the development of novel antimicrobU19AI109764 · NIAID · HARVARD MEDICAL SCHOOL · PI BELTZ, GERALD A · 2014 to 2018
$25.2M
Studies Toward Hybrid Glycopeptide AntibioticsR01GM066174 · NIGMS · PRINCETON UNIVERSITY · PI KAHNE, DANIEL · 2002 to 2018
$8.9M
Peptidoglycan Biogenesis in Escherichia ColiR01AI083365 · NIAID · HARVARD MEDICAL SCHOOL · PI Thomas G Bernhardt · 2010 to 2026
$8.3M
Mechanism and Inhibition of Enzymes that Assemble Bacterial Cell WallR01GM076710 · NIGMS · HARVARD MEDICAL SCHOOL · PI WALKER, SUZANNE · 2007 to 2019
$5.9M
Identifying and validating new antibiotic targets in cell wall synthesis pathwaysR01AI099144 · NIAID · HARVARD MEDICAL SCHOOL · PI BERNHARDT, THOMAS G, WALKER, SUZANNE · 2012 to 2016
$4.3M
NIAID NIH HHS R01 AI083365NIAID NIH HHS R01 AI099144NIAID NIH HHS U19 AI109764NIGMS NIH HHS R01 GM066174NIGMS NIH HHS R01 GM076710
6 · The paper itself

Abstract

To fortify their cytoplasmic membrane and protect it from osmotic rupture, most bacteria surround themselves with a peptidoglycan (PG) exoskeleton synthesized by the penicillin-binding proteins (PBPs). As their name implies, these proteins are the targets of penicillin and related antibiotics. We and others have shown that the PG synthases PBP1b and PBP1a of Escherichia coli require the outer membrane lipoproteins LpoA and LpoB, respectively, for their in vivo function. Although it has been demonstrated that LpoB activates the PG polymerization activity of PBP1b in vitro, the mechanism of activation and its physiological relevance have remained unclear. We therefore selected for variants of PBP1b (PBP1b*) that bypass the LpoB requirement for in vivo function, reasoning that they would shed light on LpoB function and its activation mechanism. Several of these PBP1b variants were isolated and displayed elevated polymerization activity in vitro, indicating that the activation of glycan polymer growth is indeed one of the relevant functions of LpoB in vivo. Moreover, the location of amino acid substitutions causing the bypass phenotype on the PBP1b structure support a model in which polymerization activation proceeds via the induction of a conformational change in PBP1b initiated by LpoB binding to its UB2H domain, followed by its transmission to the glycosyl transferase active site. Finally, phenotypic analysis of strains carrying a PBP1b* variant revealed that the PBP1b-LpoB complex is most likely not providing an important physical link between the inner and outer membranes at the division site, as has been previously proposed.

Indexed as

Bacterial Outer Membrane ProteinsBinding SitesCell WallCoenzymesComputer SimulationEnzyme ActivationEscherichia coli ProteinsModels, ChemicalModels, MolecularPenicillin-Binding ProteinsProtein BindingProtein ConformationStructure-Activity RelationshipBacterial Outer Membrane ProteinsCoenzymesEscherichia coli ProteinsLpoB protein, E coliPenicillin-Binding Proteinscell wallmureinPBPpenicillinpeptidoglycan

Identifiers

PMID27071112
PMCPMC4855605
OpenAlexW2335936816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.